Influences of Glimepiride Self-Nanoemulsifying Drug Delivery System Loaded Liquisolid Tablets on the Hypoglycemic Activity and Pancreatic Histopathological Changes in Streptozotocin-Induced Hyperglycemic Rats
Open Access
- 10 November 2022
- journal article
- research article
- Published by MDPI AG in Nanomaterials
- Vol. 12 (22) , 3966
Abstract
The development of an oral anti-diabetic medication characterized by enhanced hypoglycemic activity is in high demand. The goal was to study the hypoglycemic activity and pancreatic histopathology after the black-seed-based self-nanoemulsifying drug delivery system (SNEDDS) loaded with glimepiride liquisolid tablets to diabetic rats. The solubility of glimepiride in various vehicles was investigated. An optimization SNEDDS formulation was developed using a mixture of the experimental design approach. Box–Behnken design (BBD) was used to develop glimepiride liquisolid tablets utilizing Avicel PH 101 and Neusilin as a carrier mixture and FujiSil as a coating material. The quality attributes of the prepared tablets were assessed. Following the administration of the optimized tablets to diabetic rats, the pharmacodynamics and histopathological changes were investigated and compared to a commercial drug product. Results revealed that the optimized SNEDDS formulation that contains 15.43% w/w black seed oil, 40% w/w Tween 80, and 44.57% w/w Polyethylene glycol 400 showed an average droplet size of 34.64 ± 2.01 nm and a drug load of 36.67 ± 3.13 mg/mL. The optimized tablet formulation contained 0.31% Avicel in the carrier mixture, a 14.99 excipient ratio, and 8% superdisintegrant. Pre- and post-compression properties were satisfactory, and the optimized glimepiride liquisolid tablet showed a two-fold increase in dissolution. The optimized tablet demonstrated superior pharmacodynamics. The pancreatic tissues of the group treated with the optimized tablet displayed normal histological structure. The obtained data offered a commercially viable alternative for manufacturing solid dosage forms containing water-insoluble drugs, but additional clinical research is required.Keywords
Funding Information
- Deanship of Scientific Research (DSR)
This publication has 43 references indexed in Scilit:
- Solid self-nanoemulsifying drug delivery system (S-SNEDDS) for oral delivery of glimepiride: development and antidiabetic activity in albino rabbitsDrug Delivery, 2013
- Liquisolid Technique Based Sustained Release Tablet of Trimetazidine DihydrochlorideDrug Invention Today, 2013
- Self-Nanoemulsifying Powder of Isotretinoin: Preparation and CharacterizationJournal of Powder Technology, 2013
- Dissolution Enhancement of Rosuvastatin Calcium by Liquisolid Compact TechniqueJournal of Pharmaceutics, 2013
- History of current non-insulin medications for diabetes mellitusJournal of Community Hospital Internal Medicine Perspectives, 2012
- Investigating the Use of Liquisolid Compacts Technique to Minimize the Influence of pH Variations on Loratadine ReleaseAAPS PharmSciTech, 2011
- Preparation and Evaluation of Self-nanoemulsifying Tablets of CarvedilolAAPS PharmSciTech, 2009
- In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvinEuropean Journal of Pharmaceutical Sciences, 2007
- Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugsBiomedicine & Pharmacotherapy, 2004
- Enhancement of prednisolone dissolution properties using liquisolid compactsInternational Journal of Pharmaceutics, 1998